Q32 Bio Inc.
QTTB | NASDAQ
$10.47
-$0.07 (-0.66%)
At close: Sep 21, 2026, 4:00 PM ET
$10.98
+$0.51 (+4.85%)
Pre-market:
Sep 22, 2026, 7:55 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 53.74M | n/a | -6.65M | 6.65M | n/a | 2.7M |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 53.74M | n/a | -6.65M | 6.65M | n/a | 2.7M |
Operating Income | 16.9M | -66.1M | -48.26M | -39.23M | -36.69M | -130.26M |
Interest Income | 2.2M | 3.9M | n/a | n/a | n/a | 1.57M |
Pretax Income | 29.82M | -47.71M | -53.43M | -42.75M | -37.02M | -128.69M |
Net Income | 29.82M | -47.73M | -53.74M | -42.81M | -37.56M | -128.69M |
Selling & General & Admin | 17.68M | 17.96M | 9.88M | 10.06M | 6.76M | 23.67M |
Research & Development | 19.16M | 48.14M | 31.73M | 35.81M | 29.93M | 100.39M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 36.84M | 66.1M | 41.6M | 45.88M | 36.69M | 124.06M |
Interest Expense | 1.1M | 1.1M | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 36.84M | 66.1M | 41.6M | 45.88M | 36.69M | 132.97M |
Income Tax Expense | n/a | 21K | 318K | 62K | 547K | n/a |
Shares Outstanding (Basic) | 12.3M | 9.32M | 11.93M | 11.93M | 11.93M | 2.55M |
Shares Outstanding (Diluted) | 12.31M | 9.66M | 11.93M | 11.93M | 11.93M | 2.55M |
EPS (Basic) | 2.42 | -5.12 | -4.51 | -3.59 | -3.15 | -50.46 |
EPS (Diluted) | 2.42 | -6.58 | -4.51 | -3.59 | -3.15 | -50.46 |
EBITDA | 31.31M | -44.5M | -47.76M | -38.86M | -36.65M | -119.79M |
EBIT | 30.92M | -44.99M | -48.26M | -39.23M | -36.69M | -128.69M |
Depreciation & Amortization | 391K | 487K | 499K | 370K | 47K | 8.9M |
Add to Watchlist
Select watchlists to add or remove QTTB